_forte-trial-minimal-residual-disease-evaluation-in-newly-diagnosed-multiple-myeloma.jpg "FORTE trial: Minimal residual disease evaluation in newly diagnosed multiple myeloma from cytometry Video Screenshot Preview")
GalleryPlay Video:
(Note: The default playback of the video is HD VERSION. If your browser is buffering the video slowly, please play the REGULAR MP4 VERSION or Open The Video below for better experience. Thank you!)
⏲ Duration: 2 min 39 sec
✓ Published: 10-Jun-2020
✓ Published: 10-Jun-2020
Description:
Dr Stefania Oliva speaks to ecancer about the results of the FORTE trial, presented as part of the ASCO 2020 Virtual Meeting. nnThe phase III trial looked at multiparameter flow cytometry and next-generation sequencing for minimal residual disease evaluation in newly diagnosed multiple myeloma patients. nnProf Oliva explains how the techniques were used in the trial and reports that the results indicate that both techniques are good, but that longer follow-up is needed. nSign up to ecancer for f
Dr Stefania Oliva speaks to ecancer about the results of the FORTE trial, presented as part of the ASCO 2020 Virtual Meeting. nnThe phase III trial looked at multiparameter flow cytometry and next-generation sequencing for minimal residual disease evaluation in newly diagnosed multiple myeloma patients. nnProf Oliva explains how the techniques were used in the trial and reports that the results indicate that both techniques are good, but that longer follow-up is needed. nSign up to ecancer for f
Share with your friends:
Whatsapp | Viber | Telegram | Line | SMS
Email | Twitter | Reddit | Tumblr | Pinterest
Related Videos
_a-streamlined-laboratory-workflow-for-controlling-antibody-and-reagent-lots-on-a-12c-flow-cytometry-system.webp "July 15th, 2021nFeatured Presenter Robert Andrews, Director, Flow Cytometry Lab, LabPMM")
⏲ 29 min 76 sec ✓ 20-Jul-2021
_mammospheres.webp "Turbo RFP transfected cells in DAPI labelled mamospheresnnQueens Cancer Research InstitutenCytometry and Imaging Facility.")
_continuing-the-conversation-with-dr-marcel-henao-tamayo.webp "Dr. Marcela Henao-Tamayo, director of the Flow Cytometry Facility at Colorado State University, recently joined President Joyce McConnell as the first guest in the president's")
_biostatus-introducing-draq7.webp "http://www.biostatus.comnnFilmed & Edited by Joe BinksnProduced by Hannah Pattersonnn© Biostatus 2012")
_technological-advances-in-mrd-assessment.webp "Dr Bruno Paiva speaks to cancer at the 2019 MyKE Myeloma meeting about the latest technological advances in assessing a patient's MRD status. nnDespite being high-risk for myeloma at the time of diagnosis, these patients may be MRD negative after treatment - in which Dr Paiva describes the risk as being")
_flow-cytometry-course-model-1.webp "Flow Cytometer basic understanding for student course. nn1 of 4 video Models on Vimeo pertaining to graduate course study.")
_using-multiparameter-flow-cytometry-and-next-generation-sequencing-to-evaluate-mrd-in-patients-with-ndmm-in-the-forte-tr.webp "Dr Francesca Gay speaks to ecancer at the 2019 ASH meeting in Orlando about the use of multiparametric flow cytometry (MDC) and next generation sequencing (NGS) to characterise complete remission (CR) in patients with newly diagnosed multiple myeloma (NDMM) in the FORTE trial. nnDr Gay explains that these techniques displayed good concordance, as the rate of patients who achieve minimal residual disease (MRD) negativity were comparable between each arm. More specifically an 80 percent agreement")
⏲ 2 min 11 sec ✓ 09-Dec-2019
_lsi-virtual-seminar-series-lsi-core-facilities-jan-29-2021.webp "This January 29, 2021 Life Sciences Institute Virtual Seminar features an overview of three Core Services housed within the LSI: Bioinformatics, Flow Cytometry, and High Throughput Biology. The presentations showcase the essential support and capacity to sustain cutting edge research.")
_a-streamlined-laboratory-workflow-for-controlling-antibody-and-reagent-lots-on-a-12c-flow-cytometry-system.jpg)
_mammospheres.jpg)
_continuing-the-conversation-with-dr-marcel-henao-tamayo.jpg)
_biostatus-introducing-draq7.jpg)
_technological-advances-in-mrd-assessment.jpg)
_flow-cytometry-course-model-1.jpg)
_using-multiparameter-flow-cytometry-and-next-generation-sequencing-to-evaluate-mrd-in-patients-with-ndmm-in-the-forte-tr.jpg)
_lsi-virtual-seminar-series-lsi-core-facilities-jan-29-2021.jpg)
![[+]](/images/menu.gif){kind=small}